Increasing fish oil intake - Any net benefits?

Drug and Therapeutics Bulletin

Volumn 34, Issue 8, 1996, Pages 60-62

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

ANGIOPLASTY; ARTHRITIS; ASPIRATION PNEUMONIA; ASTHMA; BLEEDING; BLOOD PRESSURE; CLINICAL TRIAL; CROHN DISEASE; DIET SUPPLEMENTATION; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; ISCHEMIC HEART DISEASE; LIPID DIET; NAUSEA; ORAL DRUG ADMINISTRATION; PREVENTIVE MEDICINE; PSORIASIS; RESTENOSIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029737051     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1996.34860     Document Type: Short Survey

References (38)

1. Weatherall DJ, Ledingham JGG, Warrell DA (Eds). Oxford textbook of medicine. Volume 2. Oxford: Oxford University Press, 1983.
2. Cardiovascular Review Group Committee on Medical Aspects of Food Policy. Nutritional Aspects of Cardiovascular Disease. Report on Health and Social Subjects 46. London: HMSO, 1994.
3. Sanders TAB. Marine oils: metabolic effects and role in human nutrition. Proc Nutr Soc 1993; 52: 457-72.
4. Sanders TAB, Roshanai F. The influence of different types of ω3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci 1983; 64; 91-9.
5. Maxepa - eskimos, fish oils and ischaemic heart disease. DTB 1988; 26: 85-6.
6. Sanders TAB. Influence of ω3 fatty acids on blood lipids. World Rev Nutr Diet 1991; 66: 358-66.
7. Prichard BNC, Smith CCT, Ling KLE, Betteridge DJ. Fish oils and cardiovascular disease. Beneficial effects on lipids and the haemostatic system. BMJ 1995; 310: 819-20.
8. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-9.
9. Norell SE, Ahlbom A, Feychting M, Pedersen NL. Fish consumption and mortality from coronary heart disease. BMJ 1986; 293: 426.
10. Siscovick DS, Raghunathan TE, King I et al. Dietary intake and cell membrane levels of long chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363-7.
11. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995; 332: 977-82.
12. Burr ML, Fehily AM, Gilbert JF et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989; ii: 757-61.
13. Burr ML, Sweemam PM, Fehily AM. Diet and reinfarction. Eur Heart J 1994; 15: 1152-4 [letter].
14. Bairati I, Roy L, Meyer F. Double blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992; 85: 950-6.
15. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-33.
16. Appel LJ, Miller III ER, Seidler AJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? Arch Intern Med 1993; 153: 1429-38.
17. Kremer JM, Jubiz W, Michalek A et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Am Intern Med 1987; 106: 497-503.
18. Belch JJF, Ansell D, Madhok R, O'Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 1988; 47: 96-104.
19. Lau CS, Morley KD, Belch JJF. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br J Rheumatol 1993; 32: 982-9.
20. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rhuematoid arthritis. Arthritis Rheum 1994; 37: 824-9.
21. Sköldstam L, Börjesson O, Kjällman A, Seiving B, Åkesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study Scand J Rheumatol 1992; 21: 178-85.
22. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-60.
23. Bittiner SB, Tucker WFG, Cartwright I, Blechen SS. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet 1988; i: 378-80.
24. Collier PM, Ursell A, Zaremba K, Rowland Payne CME, Staughton RCD, Sanders T. Effect of regular consumption of oily fish compared with white fish on chronic plaque psoriasis. Eur Clin Nutr 1993; 47: 251-4.
25. Walton AJE, Snaith ML, Locniskar M, Cumberland AG, Morrow WJW, Isenberg DA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 463-6.
26. Westberg G, Tarkowski A. Effect of MaxEPA in patients with SLE. A double-blind, crossover study. Scand J Rheumatol 1990; 19: 137-43.
27. Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Farlardeau P. Omega-3 fatty acid dietary supplementaton in systemic lupus erythematosus. Kidney Int 1989; 36: 653-60.
28. Moore GF, Yarboro C, Sebring NG, Robinson DR, Steinberg AD. Eicosapentanoic acid (EPA) in the treatment of systemic lupus erythematosus (SLE). Arthritis Rheum 1987; 30 (suppl 4): S33 [abstract].
29. Donadio, Jr JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994; 331: 1194-9.
30. Bennett WM, Walker RG, Kincaid-Smith P. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial. Clin Nephrol 1989; 31: 128-31.
31. Stammers T, Sibbald B, Freeling P. Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice. Ann Rheum Dis 1992; 51:128-9.
32. Søyland E, Funk J, Rajka G et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol 1994; 130: 757-64.
33. Bates D, Cartlidge NEF, French JM et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 18-22.
34. Ritter JM, Taylor GW. Fish oil in asthma. Thorax 1988; 43: 81-3.
35. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1990; 228: 165-71.
36. Dawson JK, Abemethy VE, Graham DR, Lynch MP. A woman who took cod-liver oil and smoked. Lancet 1996; 347: 1804.
37. Rothman KJ, Moore LL, Singer MR, Nguyen U-SDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995, 333: 1369-73.
38. Ministry of Agriculture, Fisheries and Food. Steering Group on Chemical Aspects of Food Surveillance. Annual Report 1994. Food Surveillance Paper No 45. London: HMSO, 1995.